Email Alert RSS
Volume 15 Issue 2
Mar.  2024
Turn off MathJax
Article Contents
Abstract
References
ZHANG Song, QIU Luhong, LIU Yingxian, XU Xiqi. Interpretation of JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 320-327. DOI: 10.12290/xhyxzz.2023-0630
Citation: ZHANG Song, QIU Luhong, LIU Yingxian, XU Xiqi. Interpretation of JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 320-327. DOI: 10.12290/xhyxzz.2023-0630
shu

Interpretation of JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis

  • 1.

    Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China

  • 2.

    Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds: 

Clinical and Translational Medicine Research Program of Chinese Academy of Medical Sciences 2022-I2M-CGT-B-016

More Information
  • Corresponding author:

    XU Xiqi, E-mail: xuxiqi0928@163.com

  • Received Date: December 16, 2023
  • Accepted Date: January 01, 2024
  • Available Online: January 04, 2024
  • Issue Publish Date: March 29, 2024
    Graphical Abstract
    • Abstract
  • JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis offers a new perspective on the definition, classification, epidemiology, pathophysiology, diagnosis, diagnostic, treatment and management of myocarditis. It also provides recommendations to clinicians on the diagnosis and treatment of myocarditis which are more suitable for clinical practice. Given that no myocarditis guidance document has recently been issued in China, this article provides a comprehensive interpretation of the key points of this guideline combined with the latest research, so as to provide reference for the diagnosis and treatment of myocarditis in our country.
    • FullText(HTML)
    • References (18)
  • [1]
    Nagai T, Inomata T, Kohno T, et al. JCS 2023 guideline on the diagnosis and treatment of myocarditis[J]. Circ J, 2023, 87(5): 674-754. DOI: 10.1253/circj.CJ-22-0696
    [2]
    Weinstein C, Fenoglio J J. Myocarditis[J]. Hum Pathol, 1987, 18(6): 613-618. DOI: 10.1016/S0046-8177(87)80362-3
    [3]
    邱露虹, 刘颖娴, 徐希奇. 不容忽视的心肌炎: 来自《2021年ESC急慢性心力衰竭诊断与治疗指南》的启示[J]. 协和医学杂志, 2022, 13(4): 530-534. DOI: 10.12290/xhyxzz.2022-0077

    Qiu L H, Liu Y X, Xu X Q. Nonnegligible myocarditis: insights from 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Med J PUMCH, 2022, 13(4): 530-534. DOI: 10.12290/xhyxzz.2022-0077
    [4]
    Kociol R D, Cooper L T, Fang J C, et al. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association[J]. Circulation, 2020, 141(6): e69-e92.
    [5]
    Pahuja M, Adegbala O, Mishra T, et al. Trends in the incidence of in-hospital mortality, cardiogenic shock, and utilization of mechanical circulatory support devices in myocarditis (analysis of national inpatient sample data, 2005—2014)[J]. J Card Fail, 2019, 25(6): 457-467. DOI: 10.1016/j.cardfail.2019.04.012
    [6]
    Nguyen L S, Cooper L T, Kerneis M, et al. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database[J]. Nat Commun, 2022, 13(1): 25. DOI: 10.1038/s41467-021-27631-8
    [7]
    Ammirati E, Lupi L, Palazzini M, et al. Prevalence, characteristics, and outcomes of COVID-19-associated acute myocarditis[J]. Circulation, 2022, 145(15): 1123-1139. DOI: 10.1161/CIRCULATIONAHA.121.056817
    [8]
    Witberg G, Barda N, Hoss S, et al. Myocarditis after COVID-19 vaccination in a large health care organization[J]. N Engl J Med, 2021, 385(23): 2132-2139. DOI: 10.1056/NEJMoa2110737
    [9]
    Mevorach D, Anis E, Cedar N, et al. Myocarditis after BNT162b2 mRNA vaccine against COVID-19 in Israel[J]. N Engl J Med, 2021, 385(23): 2140-2149. DOI: 10.1056/NEJMoa2109730
    [10]
    Patone M, Mei X W, Handunnetthi L, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection[J]. Nat Med, 2022, 28(2): 410-422. DOI: 10.1038/s41591-021-01630-0
    [11]
    Karlstad Ø, Hovi P, Husby A, et al. SARS-CoV-2 vaccination and myocarditis in a Nordic cohort study of 23 million residents[J]. JAMA Cardiol, 2022, 7(6): 600-612. DOI: 10.1001/jamacardio.2022.0583
    [12]
    Lie J T. Myocarditis and endomyocardial biopsy in unexplained heart failure: a diagnosis in search of a disease[J]. Ann Intern Med, 1988, 109(7): 525-528. DOI: 10.7326/0003-4819-109-7-525
    [13]
    Aretz H T. Myocarditis: the Dallas criteria[J]. Hum Pathol, 1987, 18(6): 619-624. DOI: 10.1016/S0046-8177(87)80363-5
    [14]
    Seferović P M, Tsutsui H, McNamara D M, et al. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society position statement on endomyocardial biopsy[J]. Eur J Heart Fail, 2021, 23(6): 854-871. DOI: 10.1002/ejhf.2190
    [15]
    Yilmaz A, Kindermann I, Kindermann M, et al. Compara-tive evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance[J]. Circulation, 2010, 122(9): 900-909. DOI: 10.1161/CIRCULATIONAHA.109.924167
    [16]
    Corsten M F, Papageorgiou A, Verhesen W, et al. MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis[J]. Circ Res, 2012, 111(4): 415-425. DOI: 10.1161/CIRCRESAHA.112.267443
    [17]
    McDonagh T A, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J, 2021, 42(36): 3599-3726.
    [18]
    Ammirati E, Cipriani M, Moro C, et al. Clinical presenta-tion and outcome in a contemporary cohort of patients with acute myocarditis: multicenter lombardy registry[J]. Circulation, 2018, 138(11): 1088-1099. DOI: 10.1161/CIRCULATIONAHA.118.035319
    • Related Articles

  • Cited by

    Periodical cited type(1)

    1. 薛莲，李平，杨阳. 李平从阴虚论治慢性病毒性心肌炎经验. 中医药导报. 2024(09): 150-153 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1135) PDF downloads (269) Cited by(2)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close